Malcisbo wins the prestigious Swiss Technology Award in the category “seed” for their pioneering vaccine platform based on carbohydrates (“sweet vaccines”). The prize was handed over by Prof. Dr. Roland Siegwart (Vice President Research & Corporate relations, ETHZ) on the occasion of the Swiss Innovation Forum 2010 held at the Novartis Campus Basel.
Malcisbo AG, Wagistrasse 27a, CH-8952 Schlieren, Phone: +41 44 732 22 00, Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein.